Entera Bio (ENTX) EPS (Basic) Growth (1y) (2020 - 2026)
Entera Bio (ENTX) EPS (Basic) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,151.81% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - | -25.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.23% |
| Dec 31, 2025 | -33,369.90% |
| Sep 30, 2025 | 9.18% |
| Jun 30, 2025 | 11.15% |
| Mar 31, 2025 | -7.56% |
| Dec 31, 2024 | 8.94% |
| Sep 30, 2024 | 2.80% |
| Jun 30, 2024 | 18.64% |
| Mar 31, 2024 | 26.16% |
| Dec 31, 2023 | 34.72% |
| Sep 30, 2023 | 22.44% |
| Jun 30, 2023 | 27.01% |
| Mar 31, 2023 | 42.14% |
| Dec 31, 2022 | 32.85% |
| Sep 30, 2022 | 5.00% |
| Jun 30, 2022 | -6.04% |
| Mar 31, 2022 | -25.25% |
| Jun 30, 2021 | 40.40% |
| Jun 30, 2020 | -1.25% |